| APO-RISPERIDONE (0.25 MG) | 02282119 | Marketed | Apotex Inc. | Jul 2006 |
| APO-RISPERIDONE (0.50 MG) | 02282127 | Marketed | Apotex Inc. | Jul 2006 |
| APO-RISPERIDONE (1.0 MG) | 02282135 | Marketed | Apotex Inc. | Jul 2006 |
| APO-RISPERIDONE (2.0 MG) | 02282143 | Marketed | Apotex Inc. | Jul 2006 |
| APO-RISPERIDONE (3.0 MG) | 02282151 | Marketed | Apotex Inc. | Jul 2006 |
| APO-RISPERIDONE (4.0 MG) | 02282178 | Marketed | Apotex Inc. | Jul 2006 |
| JAMP RISPERIDONE TABLETS (0.25 MG) | 02563320 | Marketed | JAMP Pharma Corporation | Aug 2026 |
| JAMP RISPERIDONE TABLETS (0.5 MG) | 02563339 | Marketed | JAMP Pharma Corporation | Aug 2026 |
| JAMP RISPERIDONE TABLETS (1 MG) | 02563347 | Marketed | JAMP Pharma Corporation | Aug 2026 |
| JAMP RISPERIDONE TABLETS (3 MG) | 02563363 | Marketed | JAMP Pharma Corporation | Aug 2026 |
| JAMP-RISPERIDONE (0.25 MG) | 02359529 | Marketed | JAMP Pharma Corporation | Dec 2010 |
| JAMP-RISPERIDONE (0.50 MG) | 02359537 | Marketed | JAMP Pharma Corporation | Dec 2010 |
| JAMP-RISPERIDONE (1.0 MG) | 02359545 | Marketed | JAMP Pharma Corporation | Dec 2010 |
| JAMP-RISPERIDONE (2.0 MG) | 02359553 | Marketed | JAMP Pharma Corporation | Dec 2010 |
| JAMP-RISPERIDONE (3.0 MG) | 02359561 | Marketed | JAMP Pharma Corporation | Dec 2010 |
| JAMP-RISPERIDONE (4.0 MG) | 02359588 | Marketed | JAMP Pharma Corporation | Dec 2010 |
| MAR-RISPERIDONE (0.25 MG) | 02371766 | Marketed | Marcan Pharmaceuticals Inc. | Apr 2013 |
| MAR-RISPERIDONE (0.50 MG) | 02371774 | Marketed | Marcan Pharmaceuticals Inc. | Apr 2013 |
| MAR-RISPERIDONE (1.0 MG) | 02371782 | Marketed | Marcan Pharmaceuticals Inc. | Apr 2013 |
| MAR-RISPERIDONE (2.0 MG) | 02371790 | Marketed | Marcan Pharmaceuticals Inc. | Feb 2026 |
| MAR-RISPERIDONE (3.0 MG) | 02371804 | Marketed | Marcan Pharmaceuticals Inc. | Feb 2026 |
| MAR-RISPERIDONE (4 MG) | 02371812 | Marketed | Marcan Pharmaceuticals Inc. | Feb 2026 |
| MINT-RISPERIDON (0.25 MG) | 02359790 | Marketed | Mint Pharmaceuticals Inc | Jan 2011 |
| MINT-RISPERIDON (0.50 MG) | 02359804 | Marketed | Mint Pharmaceuticals Inc | Jan 2011 |
| MINT-RISPERIDON (1.0 MG) | 02359812 | Marketed | Mint Pharmaceuticals Inc | Jan 2011 |
| MINT-RISPERIDON (2.0 MG) | 02359820 | Marketed | Mint Pharmaceuticals Inc | Jan 2011 |
| MINT-RISPERIDON (3.0 MG) | 02359839 | Marketed | Mint Pharmaceuticals Inc | Jan 2011 |
| MINT-RISPERIDON (4.0 MG) | 02359847 | Marketed | Mint Pharmaceuticals Inc | Jan 2011 |
| OKEDI (75 MG) | 02544601 | Marketed | Laboratorios Farmaceuticos Rovi, S.A. | May 2025 |
| OKEDI (100 MG) | 02544628 | Marketed | Laboratorios Farmaceuticos Rovi, S.A. | May 2025 |
| PMS-RISPERIDONE (0.25 MG) | 02252007 | Marketed | Pharmascience Inc. | Jul 2006 |
| PMS-RISPERIDONE (0.5 MG) | 02252015 | Marketed | Pharmascience Inc. | Jul 2006 |
| PMS-RISPERIDONE (1.0 MG) | 02252023 | Marketed | Pharmascience Inc. | Jul 2006 |
| PMS-RISPERIDONE (2.0 MG) | 02252031 | Marketed | Pharmascience Inc. | Jul 2006 |
| PMS-RISPERIDONE (3.0 MG) | 02252058 | Marketed | Pharmascience Inc. | Jul 2006 |
| PMS-RISPERIDONE (4.0 MG) | 02252066 | Marketed | Pharmascience Inc. | Jul 2006 |
| PMS-RISPERIDONE (1 MG) | 02279266 | Marketed | Pharmascience Inc. | Jul 2006 |
| PRO-RISPERIDONE (0.25 MG) | 02312700 | Marketed | Pro Doc Limitee | Jul 2008 |
| PRO-RISPERIDONE (0.5 MG) | 02312719 | Marketed | Pro Doc Limitee | Jul 2008 |
| PRO-RISPERIDONE (1.0 MG) | 02312727 | Marketed | Pro Doc Limitee | Jul 2008 |
| PRO-RISPERIDONE (2.0 MG) | 02312735 | Marketed | Pro Doc Limitee | Jul 2008 |
| PRO-RISPERIDONE (3.0 MG) | 02312743 | Marketed | Pro Doc Limitee | Jul 2008 |
| PRO-RISPERIDONE (4.0 MG) | 02312751 | Marketed | Pro Doc Limitee | Jul 2008 |
| RISPERDAL CONSTA (25 MG) | 02255707 | Marketed | Janssen Inc. | Sep 2004 |
| RISPERDAL CONSTA (37.5 MG) | 02255723 | Marketed | Janssen Inc. | Sep 2004 |
| RISPERDAL CONSTA (50 MG) | 02255758 | Marketed | Janssen Inc. | Sep 2004 |
| RISPERDAL CONSTA (12.5 MG) | 02298465 | Marketed | Janssen Inc. | Oct 2007 |
| RISPERIDONE (0.25 MG) | 02356880 | Marketed | Sanis Health Inc. | Aug 2016 |
| RISPERIDONE (0.5 MG) | 02356899 | Marketed | Sanis Health Inc. | Aug 2016 |
| RISPERIDONE (1 MG) | 02356902 | Marketed | Sanis Health Inc. | Aug 2016 |
| RISPERIDONE (2 MG) | 02356910 | Marketed | Sanis Health Inc. | Aug 2016 |
| RISPERIDONE (3 MG) | 02356929 | Marketed | Sanis Health Inc. | Aug 2016 |
| RISPERIDONE (4 MG) | 02356937 | Marketed | Sanis Health Inc. | Aug 2016 |
| RISPERIDONE (0.25 MG) | 02533804 | Marketed | Sivem Pharmaceuticals Ulc | Sep 2026 |
| RISPERIDONE (0.5 MG) | 02533928 | Marketed | Sivem Pharmaceuticals Ulc | Sep 2026 |
| RISPERIDONE (1 MG) | 02533936 | Marketed | Sivem Pharmaceuticals Ulc | Sep 2026 |
| RISPERIDONE (2 MG) | 02533944 | Marketed | Sivem Pharmaceuticals Ulc | Sep 2026 |
| RISPERIDONE (3 MG) | 02533952 | Marketed | Sivem Pharmaceuticals Ulc | Sep 2026 |
| RISPERIDONE (4 MG) | 02533960 | Marketed | Sivem Pharmaceuticals Ulc | Sep 2026 |
| RIVA-RISPERIDONE (0.25 MG) | 02283565 | Marketed | Laboratoire Riva Inc. | Jul 2017 |
| RIVA-RISPERIDONE (1 MG) | 02283581 | Marketed | Laboratoire Riva Inc. | Jul 2017 |
| RIVA-RISPERIDONE (2 MG) | 02283603 | Marketed | Laboratoire Riva Inc. | Jul 2017 |
| RIVA-RISPERIDONE (3 MG) | 02283611 | Marketed | Laboratoire Riva Inc. | Jul 2017 |
| RIVA-RISPERIDONE (4 MG) | 02283638 | Marketed | Laboratoire Riva Inc. | Jul 2017 |
| SANDOZ RISPERIDONE (1 MG) | 02279800 | Marketed | Sandoz Canada Inc. | Jul 2006 |
| SANDOZ RISPERIDONE (2 MG) | 02279819 | Marketed | Sandoz Canada Inc. | Jul 2006 |
| SANDOZ RISPERIDONE (3 MG) | 02279827 | Marketed | Sandoz Canada Inc. | Jul 2006 |
| SANDOZ RISPERIDONE (4 MG) | 02279835 | Marketed | Sandoz Canada Inc. | Jul 2006 |
| SANDOZ RISPERIDONE (0.25 MG) | 02303655 | Marketed | Sandoz Canada Inc. | Dec 2007 |
| SANDOZ RISPERIDONE (0.5 MG) | 02303663 | Marketed | Sandoz Canada Inc. | Dec 2007 |
| TEVA-RISPERIDONE (1 MG) | 02264196 | Marketed | Teva Canada Limited | Oct 2022 |
| TEVA-RISPERIDONE (2 MG) | 02264218 | Marketed | Teva Canada Limited | Oct 2022 |
| TEVA-RISPERIDONE (3 MG) | 02264226 | Marketed | Teva Canada Limited | Oct 2022 |
| TEVA-RISPERIDONE (4 MG) | 02264234 | Marketed | Teva Canada Limited | Oct 2022 |
| TEVA-RISPERIDONE (0.25 MG) | 02282690 | Marketed | Teva Canada Limited | Oct 2022 |
| AG-RISPERIDONE (0.25 MG) | 02369079 | Dormant | Angita Pharma Inc. | Jun 2026 |
| AG-RISPERIDONE (0.5 MG) | 02369087 | Dormant | Angita Pharma Inc. | Jun 2026 |
| AG-RISPERIDONE (1 MG) | 02369095 | Dormant | Angita Pharma Inc. | Jun 2026 |
| AG-RISPERIDONE (2 MG) | 02369117 | Dormant | Angita Pharma Inc. | Jun 2026 |
| AG-RISPERIDONE (3 MG) | 02369125 | Dormant | Angita Pharma Inc. | Jun 2026 |
| AG-RISPERIDONE (4 MG) | 02369133 | Dormant | Angita Pharma Inc. | Jun 2026 |
| APO-RISPERIDONE (1 MG) | 02280396 | Dormant | Apotex Inc. | Aug 2020 |
| IPG-RISPERIDONE (0.25 MG) | 02359057 | Approved | Marcan Pharmaceuticals Inc. | Jan 2016 |
| IPG-RISPERIDONE (0.5 MG) | 02359065 | Approved | Marcan Pharmaceuticals Inc. | Jan 2016 |
| IPG-RISPERIDONE (1 MG) | 02359073 | Approved | Marcan Pharmaceuticals Inc. | Jan 2016 |
| IPG-RISPERIDONE (2 MG) | 02359081 | Approved | Marcan Pharmaceuticals Inc. | Jan 2016 |
| IPG-RISPERIDONE (3 MG) | 02359103 | Approved | Marcan Pharmaceuticals Inc. | Jan 2016 |
| IPG-RISPERIDONE (4 MG) | 02359111 | Approved | Marcan Pharmaceuticals Inc. | Jan 2016 |
| JAMP RISPERIDONE (1 MG) | 02454319 | Dormant | JAMP Pharma Corporation | Jul 2026 |
| JAMP RISPERIDONE TABLETS (2 MG) | 02563355 | Approved | JAMP Pharma Corporation | Dec 2025 |
| JAMP RISPERIDONE TABLETS (4 MG) | 02563371 | Approved | JAMP Pharma Corporation | Dec 2025 |
| LONGAVO (50 MG) | 02558440 | Approved | Teva Canada Limited | Jun 2025 |
| LONGAVO (75 MG) | 02558459 | Approved | Teva Canada Limited | Jun 2025 |
| LONGAVO (100 MG) | 02558467 | Approved | Teva Canada Limited | Jun 2025 |
| LONGAVO (125 MG) | 02558475 | Approved | Teva Canada Limited | Jun 2025 |
| NB-RISPERIDONE (0.25 MG) | 02555352 | Approved | NB Pharma Inc. | Feb 2025 |
| NB-RISPERIDONE (0.5 MG) | 02555360 | Approved | NB Pharma Inc. | Feb 2025 |
| NB-RISPERIDONE (1 MG) | 02555379 | Approved | NB Pharma Inc. | Feb 2025 |
| NB-RISPERIDONE (2 MG) | 02555387 | Approved | NB Pharma Inc. | Feb 2025 |
| NB-RISPERIDONE (3 MG) | 02555395 | Approved | NB Pharma Inc. | Feb 2025 |
| NB-RISPERIDONE (4 MG) | 02555409 | Approved | NB Pharma Inc. | Feb 2025 |
| NRA-RISPERIDONE (0.25 MG) | 02565994 | Approved | Nora Pharma Inc. | Feb 2026 |
| NRA-RISPERIDONE (0.5 MG) | 02566028 | Approved | Nora Pharma Inc. | Feb 2026 |
| NRA-RISPERIDONE (1 MG) | 02566036 | Approved | Nora Pharma Inc. | Feb 2026 |
| NRA-RISPERIDONE (2 MG) | 02566044 | Approved | Nora Pharma Inc. | Feb 2026 |
| NRA-RISPERIDONE (3 MG) | 02566060 | Approved | Nora Pharma Inc. | Feb 2026 |
| NRA-RISPERIDONE (4 MG) | 02566087 | Approved | Nora Pharma Inc. | Feb 2026 |
| RISPERIDONE (1 MG) | 02571994 | Approved | Sivem Pharmaceuticals Ulc | Sep 2026 |
| RIVA-RISPERIDONE (0.5 MG) | 02283573 | Dormant | Laboratoire Riva Inc. | Jul 2026 |
| TARO-RISPERIDONE (0.25 MG) | 02328305 | Dormant | Sun Pharma Canada Inc. | Jul 2025 |
| TARO-RISPERIDONE (0.5 MG) | 02328313 | Dormant | Sun Pharma Canada Inc. | Jul 2025 |
| TARO-RISPERIDONE (1 MG) | 02328321 | Dormant | Sun Pharma Canada Inc. | Jul 2025 |
| TARO-RISPERIDONE (2 MG) | 02328348 | Dormant | Sun Pharma Canada Inc. | Jul 2025 |
| TARO-RISPERIDONE (3 MG) | 02328364 | Dormant | Sun Pharma Canada Inc. | Jul 2025 |
| TARO-RISPERIDONE (4 MG) | 02328372 | Dormant | Sun Pharma Canada Inc. | Jul 2025 |
| TEVA-RISPERIDONE (0.5 MG) | 02264188 | Dormant | Teva Canada Limited | Oct 2022 |
| ACT RISPERIDONE (0.25 MG) | 02282585 | Cancelled Post Market | Actavis Pharma Company | Jun 2018 |
| ACT RISPERIDONE (0.5 MG) | 02282593 | Cancelled Post Market | Actavis Pharma Company | Jun 2018 |
| ACT RISPERIDONE (1 MG) | 02282607 | Cancelled Post Market | Actavis Pharma Company | Jun 2018 |
| ACT RISPERIDONE (2 MG) | 02282615 | Cancelled Post Market | Actavis Pharma Company | Jun 2018 |
| ACT RISPERIDONE (3 MG) | 02282623 | Cancelled Post Market | Actavis Pharma Company | Jun 2018 |
| ACT RISPERIDONE (4 MG) | 02282631 | Cancelled Post Market | Actavis Pharma Company | Jun 2018 |
| AVA-RISPERIDONE (1 MG) | 02364344 | Cancelled Post Market | Avanstra Inc | Aug 2014 |
| AVA-RISPERIDONE (0.25 MG) | 02367173 | Cancelled Post Market | Avanstra Inc | Aug 2014 |
| AVA-RISPERIDONE (0.5 MG) | 02367181 | Cancelled Post Market | Avanstra Inc | Aug 2014 |
| AVA-RISPERIDONE (1.0 MG) | 02367203 | Cancelled Post Market | Avanstra Inc | Aug 2014 |
| AVA-RISPERIDONE (2.0 MG) | 02367211 | Cancelled Post Market | Avanstra Inc | Aug 2014 |
| AVA-RISPERIDONE (3.0 MG) | 02367238 | Cancelled Post Market | Avanstra Inc | Aug 2014 |
| AVA-RISPERIDONE (4.0 MG) | 02367246 | Cancelled Post Market | Avanstra Inc | Aug 2014 |
| DOM-RISPERIDONE (0.25 MG) | 02278421 | Cancelled Post Market | Dominion Pharmacal | May 2025 |
| DOM-RISPERIDONE (0.5 MG) | 02278448 | Cancelled Post Market | Dominion Pharmacal | May 2025 |
| DOM-RISPERIDONE (1.0 MG) | 02278456 | Cancelled Post Market | Dominion Pharmacal | May 2025 |
| DOM-RISPERIDONE (2.0 MG) | 02278464 | Cancelled Post Market | Dominion Pharmacal | May 2025 |
| DOM-RISPERIDONE (3.0 MG) | 02278472 | Cancelled Post Market | Dominion Pharmacal | May 2025 |
| DOM-RISPERIDONE (4.0 MG) | 02278480 | Cancelled Post Market | Dominion Pharmacal | May 2025 |
| DOM-RISPERIDONE (1 MG) | 02309572 | Cancelled Pre Market | Dominion Pharmacal | May 2025 |
| DOM-RISPERIDONE ODT (0.5 MG) | 02294478 | Cancelled Pre Market | Dominion Pharmacal | May 2025 |
| DOM-RISPERIDONE ODT (1 MG) | 02294486 | Cancelled Pre Market | Dominion Pharmacal | May 2025 |
| DOM-RISPERIDONE ODT (2 MG) | 02294494 | Cancelled Pre Market | Dominion Pharmacal | May 2025 |
| MYLAN-RISPERIDONE (0.25 MG) | 02282240 | Cancelled Post Market | Mylan Pharmaceuticals Ulc | Feb 2018 |
| MYLAN-RISPERIDONE (0.50 MG) | 02282259 | Cancelled Post Market | Mylan Pharmaceuticals Ulc | Feb 2018 |
| MYLAN-RISPERIDONE (1 MG) | 02282267 | Cancelled Post Market | Mylan Pharmaceuticals Ulc | Oct 2017 |
| MYLAN-RISPERIDONE (2 MG) | 02282275 | Cancelled Post Market | Mylan Pharmaceuticals Ulc | Oct 2017 |
| MYLAN-RISPERIDONE (3 MG) | 02282283 | Cancelled Post Market | Mylan Pharmaceuticals Ulc | Oct 2017 |
| MYLAN-RISPERIDONE (4 MG) | 02282291 | Cancelled Post Market | Mylan Pharmaceuticals Ulc | Oct 2017 |
| MYLAN-RISPERIDONE ODT (0.5 MG) | 02413485 | Cancelled Post Market | Mylan Pharmaceuticals Ulc | Nov 2021 |
| MYLAN-RISPERIDONE ODT (1 MG) | 02413493 | Cancelled Post Market | Mylan Pharmaceuticals Ulc | Nov 2021 |
| MYLAN-RISPERIDONE ODT (2 MG) | 02413507 | Cancelled Post Market | Mylan Pharmaceuticals Ulc | Nov 2021 |
| MYLAN-RISPERIDONE ODT (3 MG) | 02413515 | Cancelled Post Market | Mylan Pharmaceuticals Ulc | Nov 2021 |
| MYLAN-RISPERIDONE ODT (4 MG) | 02413523 | Cancelled Post Market | Mylan Pharmaceuticals Ulc | Nov 2021 |
| NU-RISPERIDONE (0.25 MG) | 02334372 | Cancelled (Unreturned Annual) | Nu-Pharm Inc | Mar 2018 |
| NU-RISPERIDONE (0.5 MG) | 02334380 | Cancelled (Unreturned Annual) | Nu-Pharm Inc | Mar 2018 |
| NU-RISPERIDONE (1 MG) | 02334399 | Cancelled (Unreturned Annual) | Nu-Pharm Inc | Mar 2018 |
| NU-RISPERIDONE (2 MG) | 02334402 | Cancelled (Unreturned Annual) | Nu-Pharm Inc | Mar 2018 |
| NU-RISPERIDONE (3 MG) | 02334410 | Cancelled (Unreturned Annual) | Nu-Pharm Inc | Mar 2018 |
| NU-RISPERIDONE (4 MG) | 02334429 | Cancelled (Unreturned Annual) | Nu-Pharm Inc | Mar 2018 |
| PERSERIS (90 MG) | 02507838 | Cancelled Post Market | Hls Therapeutics Inc | Jul 2024 |
| PERSERIS (120 MG) | 02507846 | Cancelled Post Market | Hls Therapeutics Inc | Jul 2024 |
| PHL-RISPERIDONE (0.25 MG) | 02258439 | Cancelled Post Market | Pharmel Inc. | Aug 2006 |
| PHL-RISPERIDONE (0.5 MG) | 02258447 | Cancelled Post Market | Pharmel Inc. | Aug 2006 |
| PHL-RISPERIDONE (1.0 MG) | 02258455 | Cancelled Post Market | Pharmel Inc. | Aug 2006 |
| PHL-RISPERIDONE (2.0 MG) | 02258463 | Cancelled Post Market | Pharmel Inc. | Aug 2006 |
| PHL-RISPERIDONE (3.0 MG) | 02258471 | Cancelled Post Market | Pharmel Inc. | Aug 2006 |
| PHL-RISPERIDONE (4.0 MG) | 02258498 | Cancelled Post Market | Pharmel Inc. | Aug 2006 |
| PHL-RISPERIDONE ODT (0.5 MG) | 02294435 | Cancelled Pre Market | Pharmel Inc. | Sep 2017 |
| PHL-RISPERIDONE ODT (1 MG) | 02294443 | Cancelled Pre Market | Pharmel Inc. | Sep 2017 |
| PHL-RISPERIDONE ODT (2 MG) | 02294451 | Cancelled Pre Market | Pharmel Inc. | Sep 2017 |
| PMS-RISPERIDONE ODT (0.5 MG) | 02291770 | Cancelled Post Market | Pharmascience Inc. | Jan 2019 |
| PMS-RISPERIDONE ODT (1 MG) | 02291789 | Cancelled Post Market | Pharmascience Inc. | Jan 2019 |
| PMS-RISPERIDONE ODT (2 MG) | 02291797 | Cancelled Post Market | Pharmascience Inc. | Jan 2019 |
| PMS-RISPERIDONE ODT (3 MG) | 02370697 | Cancelled Post Market | Pharmascience Inc. | Jan 2019 |
| PMS-RISPERIDONE ODT (4 MG) | 02370700 | Cancelled Post Market | Pharmascience Inc. | Jan 2019 |
| Q-RISPERIDONE (0.25 MG) | 02372622 | Cancelled Pre Market | Qd Pharmaceuticals Ulc | Aug 2015 |
| Q-RISPERIDONE (0.5 MG) | 02372630 | Cancelled Pre Market | Qd Pharmaceuticals Ulc | Aug 2015 |
| Q-RISPERIDONE (1 MG) | 02372649 | Cancelled Pre Market | Qd Pharmaceuticals Ulc | Aug 2015 |
| Q-RISPERIDONE (2 MG) | 02372657 | Cancelled Pre Market | Qd Pharmaceuticals Ulc | Aug 2015 |
| Q-RISPERIDONE (3 MG) | 02372665 | Cancelled Pre Market | Qd Pharmaceuticals Ulc | Aug 2015 |
| Q-RISPERIDONE (4 MG) | 02372673 | Cancelled Pre Market | Qd Pharmaceuticals Ulc | Aug 2015 |
| RAN-RISPERIDONE (0.25 MG) | 02280906 | Cancelled Post Market | Ranbaxy Pharmaceuticals Canada Inc. | Jun 2012 |
| RAN-RISPERIDONE (0.5 MG) | 02280914 | Cancelled Post Market | Ranbaxy Pharmaceuticals Canada Inc. | Jun 2012 |
| RAN-RISPERIDONE (1 MG) | 02280922 | Cancelled Post Market | Ranbaxy Pharmaceuticals Canada Inc. | Jun 2012 |
| RAN-RISPERIDONE (2 MG) | 02280930 | Cancelled Post Market | Ranbaxy Pharmaceuticals Canada Inc. | Jun 2012 |
| RAN-RISPERIDONE (3 MG) | 02280949 | Cancelled Post Market | Ranbaxy Pharmaceuticals Canada Inc. | Jun 2012 |
| RAN-RISPERIDONE (4 MG) | 02280957 | Cancelled Post Market | Ranbaxy Pharmaceuticals Canada Inc. | Jun 2012 |
| RATIO-RISPERIDONE (0.25 MG) | 02264757 | Cancelled Post Market | Ratiopharm Inc Division Of Teva Canada Limited | Oct 2015 |
| RATIO-RISPERIDONE (0.5 MG) | 02264765 | Cancelled Post Market | Ratiopharm Inc Division Of Teva Canada Limited | Oct 2015 |
| RATIO-RISPERIDONE (1.0 MG) | 02264773 | Cancelled Post Market | Ratiopharm Inc Division Of Teva Canada Limited | Oct 2015 |
| RATIO-RISPERIDONE (2.0 MG) | 02264781 | Cancelled Post Market | Ratiopharm Inc Division Of Teva Canada Limited | Oct 2015 |
| RATIO-RISPERIDONE (3.0 MG) | 02264803 | Cancelled Post Market | Ratiopharm Inc Division Of Teva Canada Limited | Oct 2015 |
| RATIO-RISPERIDONE (4.0 MG) | 02264811 | Cancelled Post Market | Ratiopharm Inc Division Of Teva Canada Limited | Oct 2015 |
| RISPERDAL (2 MG) | 02025299 | Cancelled Post Market | Janssen Inc. | Mar 2019 |
| RISPERDAL (1 MG) | 02025280 | Cancelled Post Market | Janssen Inc. | Mar 2019 |
| RISPERDAL (3 MG) | 02025302 | Cancelled Post Market | Janssen Inc. | Mar 2019 |
| RISPERDAL (4 MG) | 02025310 | Cancelled Post Market | Janssen Inc. | Mar 2019 |
| RISPERDAL (5 MG) | 02230455 | Cancelled Post Market | Janssen Inc. | Aug 2009 |
| RISPERDAL (0.25 MG) | 02240551 | Cancelled Post Market | Janssen Inc. | Mar 2019 |
| RISPERDAL (0.5 MG) | 02240552 | Cancelled Post Market | Janssen Inc. | Mar 2019 |
| RISPERDAL M-TAB (0.5 MG) | 02247704 | Cancelled Post Market | Janssen Inc. | May 2017 |
| RISPERDAL M-TAB (1 MG) | 02247705 | Cancelled Post Market | Janssen Inc. | Feb 2017 |
| RISPERDAL M-TAB (2 MG) | 02247706 | Cancelled Post Market | Janssen Inc. | Jan 2017 |
| RISPERDAL M-TAB (3 MG) | 02268086 | Cancelled Post Market | Janssen Inc. | Nov 2016 |
| RISPERDAL M-TAB (4 MG) | 02268094 | Cancelled Post Market | Janssen Inc. | Sep 2016 |
| RISPERDAL ORAL SOLUTION (1 MG) | 02236950 | Cancelled Post Market | Janssen Inc. | Sep 2023 |
| RISPERIDONE (0.25 MG) | 02303485 | Cancelled Post Market | Meliapharm Inc | Jun 2014 |
| RISPERIDONE (0.5 MG) | 02303493 | Cancelled Post Market | Meliapharm Inc | Jun 2014 |
| RISPERIDONE (1.0 MG) | 02303507 | Cancelled Post Market | Meliapharm Inc | Jun 2014 |
| RISPERIDONE (2.0 MG) | 02303515 | Cancelled Post Market | Meliapharm Inc | Jun 2014 |
| RISPERIDONE (3.0 MG) | 02303523 | Cancelled Post Market | Meliapharm Inc | Jun 2014 |
| RISPERIDONE (4.0 MG) | 02303531 | Cancelled Post Market | Meliapharm Inc | Jun 2014 |
| RISPERIDONE (0.25 MG) | 02343711 | Cancelled Pre Market | Cobalt Pharmaceuticals Incorporated | Sep 2017 |
| RISPERIDONE (0.5 MG) | 02343738 | Cancelled Pre Market | Cobalt Pharmaceuticals Incorporated | Sep 2017 |
| RISPERIDONE (1.0 MG) | 02343746 | Cancelled Pre Market | Cobalt Pharmaceuticals Incorporated | Sep 2017 |
| RISPERIDONE (2.0 MG) | 02343754 | Cancelled Pre Market | Cobalt Pharmaceuticals Incorporated | Sep 2017 |
| RISPERIDONE (3.0 MG) | 02343762 | Cancelled Pre Market | Cobalt Pharmaceuticals Incorporated | Sep 2017 |
| RISPERIDONE (4.0 MG) | 02343770 | Cancelled Pre Market | Cobalt Pharmaceuticals Incorporated | Sep 2017 |
| RISPERIDONE - 0.25 (0.25 MG) | 02296756 | Cancelled Post Market | Pro Doc Limitee | Jul 2008 |
| RISPERIDONE - 0.5 (0.50 MG) | 02296764 | Cancelled Post Market | Pro Doc Limitee | Jul 2008 |
| RISPERIDONE - 1 (1.0 MG) | 02296772 | Cancelled Post Market | Pro Doc Limitee | Jul 2008 |
| RISPERIDONE - 2 (2.0 MG) | 02296780 | Cancelled Post Market | Pro Doc Limitee | Jul 2008 |
| RISPERIDONE - 3 (3.0 MG) | 02296799 | Cancelled Post Market | Pro Doc Limitee | Jul 2008 |
| RISPERIDONE - 4 (4.0 MG) | 02296802 | Cancelled Post Market | Pro Doc Limitee | Jul 2008 |
| RISPERIDONE TABLETS (0.25 MG) | 02332051 | Cancelled Pre Market | Ranbaxy Pharmaceuticals Canada Inc. | Jul 2025 |
| RISPERIDONE TABLETS (0.5 MG) | 02332078 | Cancelled Pre Market | Ranbaxy Pharmaceuticals Canada Inc. | Jul 2025 |
| RISPERIDONE TABLETS (1.0 MG) | 02332086 | Cancelled Pre Market | Ranbaxy Pharmaceuticals Canada Inc. | Jul 2025 |
| RISPERIDONE TABLETS (2.0 MG) | 02332094 | Cancelled Pre Market | Ranbaxy Pharmaceuticals Canada Inc. | Jul 2025 |
| RISPERIDONE TABLETS (3.0 MG) | 02332108 | Cancelled Pre Market | Ranbaxy Pharmaceuticals Canada Inc. | Jul 2025 |
| RISPERIDONE TABLETS (4.0 MG) | 02332116 | Cancelled Pre Market | Ranbaxy Pharmaceuticals Canada Inc. | Jul 2025 |
| SANDOZ RISPERIDONE (0.5 MG) | 02279495 | Cancelled Post Market | Sandoz Canada Inc. | Aug 2008 |
| SANDOZ RISPERIDONE (0.25 MG) | 02279509 | Cancelled Post Market | Sandoz Canada Inc. | Aug 2008 |
| SANDOZ RISPERIDONE (0.25 MG) | 02292807 | Cancelled Post Market | Sandoz Canada Inc. | Aug 2008 |